Artrya Says US Health System Agrees to In-Principle Participation in Cardiovascular Study

MT Newswires Live

02/02

Artrya (ASX:AYA) said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.

The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.

Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2608827108"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2608827108\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2608827108?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-02 07:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2608827108","market":"hk","top_or_hot":-1,"title":"Artrya Says US Health System Agrees to In-Principle Participation in Cardiovascular Study","media":"MT Newswires Live","content":"<html><body><p> Artrya (ASX:AYA) said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.</p><p>The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.</p><p>Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Artrya Says US Health System Agrees to In-Principle Participation in Cardiovascular Study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArtrya Says US Health System Agrees to In-Principle Participation in Cardiovascular Study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-02-02 07:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Artrya (ASX:AYA) said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.</p><p>The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.</p><p>Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AYA.AU","symbol_name":"ARTRYA LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2608827108","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2608827108","pubTimestamp":1769988773,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Artrya  said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AYA.AU":"ARTRYA LTD","BK4082":"医疗保健设备","CSII":"Cardiovascular Systems","BK7094":"医疗保健技术"},"translate_title":"Artrya表示美国卫生系统原则上同意参与心血管研究","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSII":1.5,"AYA.AU":1},"content_text":"Artrya (ASX:AYA) said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}